Vitamin E metabolites as potent inhibitors of 5-lipoxygenase

被引：0

作者：

Koeberle, A. ^{[1
]}

Waltenberger, B. ^{[2
,3
]}

Temml, V ^{[3
,4
]}

Schuster, D. ^{[3
,4
]}

Sautebin, L. ^{[5
]}

Stuppner, H. ^{[2
,3
]}

Richomme, P. ^{[6
]}

Werz, O. ^{[1
]}

机构：

[1] Univ Jena, Chair Pharmaceut Med Chem, D-07745 Jena, Germany

[2] Univ Innsbruck, Inst Pharmacognosy, A-6020 Innsbruck, Austria

[3] Univ Innsbruck, Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Austria

[4] Univ Innsbruck, Inst Pharmaceut Chem, A-6020 Innsbruck, Austria

[5] Univ Naples Federico II, Dept Pharm, Naples, Italy

[6] SONAS, UFR Sci Pharmaceut & Ingn Sante, Angers, France

来源：

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2015年 / 388卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

103

引用

页码：S26 / S27

页数：2

共 50 条

[31] Therapeutic options for 5-lipoxygenase inhibitors
Werz, Oliver
Steinhilber, Dieter
PHARMACOLOGY & THERAPEUTICS, 2006, 112 (03) : 701 - 718
[32] 5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity
Fischer, A. S.
Metzner, J.
Steinbrink, S. D.
Ulrich, S.
Angioni, C.
Geisslinger, G.
Steinhilber, D.
Maier, T. J.
BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (04) : 936 - 949
[33] DIPYRIDAMOLE - A POTENT AND SPECIFIC 5-LIPOXYGENASE INHIBITOR
CARTER, GW
DYER, R
YOUNG, P
FEDERATION PROCEEDINGS, 1985, 44 (04) : 904 - 904
[34] CONVERSION OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS INTO EITHER DUAL INHIBITORS OF 5-LIPOXYGENASE AND CYCLOOXYGENASE OR INTO SELECTIVE INHIBITORS OF 5-LIPOXYGENASE
BOSCHELLI, DH
CONNOR, DT
BORNEMEIER, DA
DYER, RD
KUIPERS, PJ
WRIGHT, CD
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 123 - MEDI
[35] HYDROXAMIC ACID INHIBITORS OF 5-LIPOXYGENASE
SUMMERS, JB
MAZDIYASNI, H
HOLMS, JH
RATAJCZYK, JD
DYER, RD
CARTER, GW
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (03) : 574 - 580
[36] STUDIES ON THE SYNTHESIS OF 5-LIPOXYGENASE INHIBITORS
SHIRAISHI, M
KATO, K
OHKAWA, S
TERAO, S
JOURNAL OF PHARMACOBIO-DYNAMICS, 1984, 7 (05): : S95 - S95
[37] Inhibitors of the 5-Lipoxygenase Pathway in Atherosclerosis
Back, Magnus
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (27) : 3116 - 3132
[38] E-2-pyrrolizin-5-yl acrylic acids as potent dual or selective inhibitors of bovine cyclooxygenase and 5-lipoxygenase
Dannhardt, G
Kiefer, W
Nowe, U
ARCHIV DER PHARMAZIE, 1995, 328 (09) : 681 - 686
[39] Conversion of cyclooxygenase inhibitors into hydroxythiazole 5-lipoxygenase inhibitors
Kerdesky, FAJ
Brooks, CDW
Hulkower, KI
Bouska, JB
Bell, RL
BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (02) : 393 - 396
[40] Novel imidazole compounds as a new series of potent, orally active inhibitors of 5-lipoxygenase
Mano, T
Stevens, RW
Ando, K
Nakao, K
Okumura, Y
Sakakibara, M
Okumura, T
Tamura, T
Miyamoto, K
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (18) : 3879 - 3887

← 1 2 3 4 5 →